Howard C Herrmann

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi request reprint A multicenter study of the tolerability of tirofiban versus placebo in patients undergoing planned intracoronary stent placement
    Craig P Juergens
    Department of Cardiology, Liverpool Hospital, Australia
    Clin Ther 24:1332-44. 2002
  2. ncbi request reprint Clinical use of AcuNav diagnostic ultrasound catheter imaging during left heart radiofrequency ablation and transcatheter closure procedures
    Jian Fang Ren
    Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104, USA
    J Am Soc Echocardiogr 15:1301-8. 2002
  3. ncbi request reprint Prevention of cardiovascular events after percutaneous coronary intervention
    Howard C Herrmann
    N Engl J Med 350:2708-10. 2004
  4. ncbi request reprint Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial results
    Howard C Herrmann
    Hospital of the University of Pennsylvania, Philadelphia, 19104, USA
    J Sex Med 3:303-8. 2006
  5. ncbi request reprint Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the Evalve MitraClip: lessons learned from EVEREST I
    Frank E Silvestry
    Cardiovascular Division, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
    J Am Soc Echocardiogr 20:1131-40. 2007
  6. doi request reprint Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis
    Howard C Herrmann
    Interventional Cardiology Program, Hospital of the University of Pennsylvania, 9038 Gates Pavilion, 3400 Spruce St, Philadelphia, PA 19104, USA
    Circulation 127:2316-26. 2013
  7. ncbi request reprint Percutaneous valve repair and placement
    Howard C Herrmann
    Interventional Cardiology Laboratory, University of Pennsylvania Health System, 3400 Spruce Street, 9 Founders Pavilion, Philadelphia, PA 19104, USA
    J Invasive Cardiol 16:59S-64S. 2004
  8. doi request reprint Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial
    Howard C Herrmann
    Interventional Cardiology and Cardiac Catheterization Labs, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104 4283, USA
    J Am Coll Cardiol 59:1312-9. 2012
  9. ncbi request reprint Percutaneous patent foramen ovale and atrial septal defect closure in adults: results and device comparison in 100 consecutive implants at a single center
    Howard C Herrmann
    Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Catheter Cardiovasc Interv 64:197-203. 2005
  10. doi request reprint Results of the Society of Cardiac Angiography and Interventions survey of physicians and training directors on procedures for structural and valvular heart disease
    Howard C Herrmann
    Cardiology Division, Department of Medicine, Hospital of the University of Pennsylvania, Gates Pavilion, Philadelphia, Pennsylvania 19104, USA
    Catheter Cardiovasc Interv 76:E106-10. 2010

Detail Information

Publications76

  1. ncbi request reprint A multicenter study of the tolerability of tirofiban versus placebo in patients undergoing planned intracoronary stent placement
    Craig P Juergens
    Department of Cardiology, Liverpool Hospital, Australia
    Clin Ther 24:1332-44. 2002
    ....
  2. ncbi request reprint Clinical use of AcuNav diagnostic ultrasound catheter imaging during left heart radiofrequency ablation and transcatheter closure procedures
    Jian Fang Ren
    Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104, USA
    J Am Soc Echocardiogr 15:1301-8. 2002
    ..AcuNav ultrasound catheter (UC) (10F, 5.5-10 MHz) has unique advantages for left heart imaging with its 4-way tip flexible maneuverability, maximal 16-cm intracardiac imaging depth, and Doppler and color flow imaging capability...
  3. ncbi request reprint Prevention of cardiovascular events after percutaneous coronary intervention
    Howard C Herrmann
    N Engl J Med 350:2708-10. 2004
  4. ncbi request reprint Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial results
    Howard C Herrmann
    Hospital of the University of Pennsylvania, Philadelphia, 19104, USA
    J Sex Med 3:303-8. 2006
    ..Erectile dysfunction (ED) may be one manifestation of a generalized vascular disorder characterized by endothelial dysfunction. Statin drugs may improve endothelial function, even before altering the lipid profile...
  5. ncbi request reprint Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the Evalve MitraClip: lessons learned from EVEREST I
    Frank E Silvestry
    Cardiovascular Division, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
    J Am Soc Echocardiogr 20:1131-40. 2007
    ..transesophageal echocardiography (TEE) is used as the primary imaging modality to guide this procedure and is essential to its success...
  6. doi request reprint Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis
    Howard C Herrmann
    Interventional Cardiology Program, Hospital of the University of Pennsylvania, 9038 Gates Pavilion, 3400 Spruce St, Philadelphia, PA 19104, USA
    Circulation 127:2316-26. 2013
    ..The prognosis and treatment of patients with low-flow (LF) severe aortic stenosis are controversial...
  7. ncbi request reprint Percutaneous valve repair and placement
    Howard C Herrmann
    Interventional Cardiology Laboratory, University of Pennsylvania Health System, 3400 Spruce Street, 9 Founders Pavilion, Philadelphia, PA 19104, USA
    J Invasive Cardiol 16:59S-64S. 2004
    ....
  8. doi request reprint Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial
    Howard C Herrmann
    Interventional Cardiology and Cardiac Catheterization Labs, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104 4283, USA
    J Am Coll Cardiol 59:1312-9. 2012
    ....
  9. ncbi request reprint Percutaneous patent foramen ovale and atrial septal defect closure in adults: results and device comparison in 100 consecutive implants at a single center
    Howard C Herrmann
    Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Catheter Cardiovasc Interv 64:197-203. 2005
    ..This single-center experience with percutaneous device closure of PFO and ASD in adults demonstrates excellent results with few complications...
  10. doi request reprint Results of the Society of Cardiac Angiography and Interventions survey of physicians and training directors on procedures for structural and valvular heart disease
    Howard C Herrmann
    Cardiology Division, Department of Medicine, Hospital of the University of Pennsylvania, Gates Pavilion, Philadelphia, Pennsylvania 19104, USA
    Catheter Cardiovasc Interv 76:E106-10. 2010
    ..Minimal information is available on the number and type of procedures being performed for structural and valvular heart disease, the physicians who perform these procedures, and on the training requirements for this emerging field...
  11. doi request reprint Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals
    Howard C Herrmann
    Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    JACC Cardiovasc Interv 2:917-24. 2009
    ..We hypothesized that patients most likely to benefit would be those at high risk with a shorter duration of acute ischemia and who required transfer for percutaneous coronary intervention (PCI)...
  12. ncbi request reprint Mitral valve hemodynamic effects of percutaneous edge-to-edge repair with the MitraClip device for mitral regurgitation
    Howard C Herrmann
    Cardiac Catheterization Laboratories, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Catheter Cardiovasc Interv 68:821-8. 2006
    ..The effects on the mitral valve gradient (MVG) and mitral valve area (MVA) are not known...
  13. ncbi request reprint Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient
    Howard C Herrmann
    Interventional Cardiology and Cardiac Catheterization Laboratories, Hospital of the University of Pennsylvania, 3400 Spruce Street, 9038 Gates Building, Philadelphia, PA 19104, USA
    EuroIntervention 4:437-42. 2009
    ..Percutaneous repair of mitral regurgitation (MR) by leaflet apposition using a clip deployed via transseptal catheterisation is undergoing evaluation...
  14. ncbi request reprint Update and rationale for ongoing acute myocardial infarction trials: combination therapy, facilitation, and myocardial preservation
    Howard C Herrmann
    Cardiac Catheterization Laboratories, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Am Heart J 151:S30-9. 2006
    ....
  15. ncbi request reprint Benefit of an early invasive management strategy in women with acute coronary syndromes
    Ruchira Glaser
    Department of Medicine, University of Pennsylvania, Philadelphia, USA
    JAMA 288:3124-9. 2002
    ..However, these studies were performed prior to the widespread use of platelet glycoprotein IIb/IIIa inhibitors and intracoronary stents...
  16. ncbi request reprint Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PR
    C Michael Gibson
    TIMI Study Group, Cardiovascular Division, Brigham and Women s Hospital, Boston, MA, USA
    Am Heart J 152:756-61. 2006
    ..A variety of imaging modalities have implicated impaired myocardial perfusion in the pathogenesis of acute coronary syndromes (ACSs)...
  17. doi request reprint Procedural and clinical outcomes of the valve-in-valve technique for severe aortic insufficiency after balloon-expandable transcatheter aortic valve replacement
    Jay Giri
    Department of Medicine, Cardiovascular Divison, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Catheter Cardiovasc Interv 80:139-47. 2012
    ..To describe the clinical and procedural outcomes of patients treated with the valve-in-valve technique for severe aortic insufficiency (AI) after balloon-expandable transcatheter aortic valve replacement (TAVR)...
  18. ncbi request reprint Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter-based embolic protection
    Michael Jonas
    Cardiovascular Division, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    Eur Heart J 27:920-8. 2006
    ..IIb/IIIa antagonists have not been proven effective during SVG intervention. We hypothesized that adjunctive use of these agents might enhance the efficacy of embolic protection devices...
  19. ncbi request reprint Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial
    Ajay J Kirtane
    Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, USA
    J Am Coll Cardiol 47:2374-9. 2006
    ..We aimed to identify correlates of Thrombolysis In Mycocardial Infarction (TIMI) major/minor bleeding among eptifibatide-treated patients undergoing percutaneous coronary intervention (PCI)...
  20. doi request reprint "Double wire" angio-seal closure technique after balloon aortic valvuloplasty
    Quang T Bui
    Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Catheter Cardiovasc Interv 75:488-92. 2010
    ..To report the feasibility of a collagen-mediated closure device using a modified Angio-Seal closure technique for access site management following percutaneous balloon aortic valvuloplasty (BAV)...
  21. doi request reprint Comparison of invasive and noninvasive assessment of aortic stenosis severity in the elderly
    Zachary M Gertz
    Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Circ Cardiovasc Interv 5:406-14. 2012
    ..Accurate assessment of AVA is crucial to determine which patients are appropriate candidates for aortic valve replacement...
  22. ncbi request reprint Acute decompensation of hypertrophic obstructive cardiomyopathy secondary to A-V disassociation: successful treatment with a combination of alcohol septal ablation and permanent pacemaker
    Sameer Rohatgi
    Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Interv Cardiol 18:401-6. 2005
    ..This case report is also a unique description of alcohol septal ablation being performed emergently to improve hemodynamics and the urgent implantation of a permanent pacemaker to return A-V synchrony...
  23. doi request reprint Percutaneous transcatheter closure of patent foramen ovale with the Amplatzer Cribriform septal occluder
    Frank E Silvestry
    Cardiovascular Division, Department of Medicine Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Catheter Cardiovasc Interv 71:383-7. 2008
    ..We tested the feasibility of percutaneous patent foramen ovale (PFO) closure utilizing the Amplatzer multifenestrated Cribriform atrial septal occluder device...
  24. ncbi request reprint Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trial
    Mitchell J Ross
    Division of Cardiology, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA
    J Am Coll Cardiol 42:981-8. 2003
    ..We sought to assess whether pre-procedural angiographic characteristics are associated with adverse clinical outcomes after coronary stenting with glycoprotein IIb/IIIa inhibition...
  25. ncbi request reprint Unprotected left main "kissing" stent implantation with a percutaneous ventricular assist device
    Srihari S Naidu
    Cardiology Department, Hospital of the University of Pennsylvania, 3400 Spruce Street, 9 Founders, Philadelphia, PA 19104, USA
    J Invasive Cardiol 16:683-4. 2004
  26. ncbi request reprint The role of risk stratification in the decision to provide upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: a cost-effectiveness analysis
    Ruchira Glaser
    Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Am Coll Cardiol 47:529-37. 2006
    ....
  27. ncbi request reprint FilterWire distal embolic protection device for vein graft stenting: initial single-center experience
    Daniel M Kolansky
    Division of Cardiovascular Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Clin Cardiol 28:556-60. 2005
    ..The FilterWire distal embolic protection device has recently been approved as an adjunct to SVG intervention. We report here our initial experience in a single center in 30 consecutive patients using this device in SVG stenting...
  28. doi request reprint The progression of a transcatheter aortic valve program: a decision analysis of more than 680 patient referrals
    Joseph E Bavaria
    Division of Cardiovascular Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Ann Thorac Surg 92:2072-6; discussion 2076-7. 2011
    ..This is an overview of one site's management strategy for patient referrals...
  29. ncbi request reprint One-year clinical outcomes of protected and unprotected left main coronary artery stenting
    Michael P Kelley
    Hospital of the University of Pennsylvania, University Health System, 9 Gates, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Eur Heart J 24:1554-9. 2003
    ..To evaluate outcomes for left main coronary artery (LMCA) stenting and compare results between protected (left coronary grafted) and unprotected LMCA stenting in the current bare-metal stent era...
  30. ncbi request reprint Transcatheter device closure of interatrial septal defects in patients with hypoxia
    Leonard Ilkhanoff
    Hospital of the University of Pennsylvania, Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, PA 19104 4283, USA
    J Interv Cardiol 18:227-32. 2005
    ..There has been growing interest in transcatheter closure of interatrial septal defects (IASDs) for a variety of indications, but reports are limited in patients with hypoxia from right-to-left shunting...
  31. ncbi request reprint Left main coronary embolism
    Victor M Mejia
    Cardiology Department and Cardiothoracic Surgery Department, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    J Invasive Cardiol 18:296. 2006
    ..Coronary angiography revealed an embolus in the left main artery which was treated with rheolytic thrombectomy. This represents an uncommon cause of acute myocardial infarction...
  32. doi request reprint Characteristics of adult patients with atrial septal defects presenting with paradoxical embolism
    Amr Bannan
    Department of Medicine, Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Catheter Cardiovasc Interv 74:1066-9. 2009
    ..The correlation between atrial septal defect (ASD) in adults and paradoxical embolism is less well defined...
  33. pmc The effect of surgical and transcatheter aortic valve replacement on mitral annular anatomy
    Mathieu Vergnat
    Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Ann Thorac Surg 95:614-9. 2013
    ..This study compares the immediate impact of transcatheter aortic valve replacement (TAVR) and standard surgical aortic valve replacement (AVR) on mitral annular anatomy...
  34. ncbi request reprint Safety of vascular closure devices--are women different?
    Ruchira Glaser
    Associate Professor of Medicine, Director, Interventional Cardiology Research, Cardiovascular Medicine, Hospital of the University of Pennsylvania, 3400 Spruce St, Gates Bldg, Room GA8 14, Philadelphia, PA, 19104, USA
    J Invasive Cardiol 16:464-5. 2004
  35. ncbi request reprint Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome
    C Michael Gibson
    TIMI Study Group, Cardiovascular Division, Brigham and Women s Hospital and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 97:1473-7. 2006
    ..In conclusion, patients undergoing DES implantation achieved more reductions in periprocedural markers of inflammation and necrosis than patients receiving bare metal stents among those with non-ST-elevation acute coronary syndrome...
  36. ncbi request reprint The role of platelets and platelet inhibition in acute myocardial infarction
    Nicholas Valettas
    Cardiovascular Division, University of Pennsylvania Medical Center, Philadelphia, USA
    Coron Artery Dis 14:357-63. 2003
  37. doi request reprint Echocardiography-guided interventions
    Frank E Silvestry
    University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA
    J Am Soc Echocardiogr 22:213-31; quiz 316-7. 2009
    ..The use of imaging techniques to guide even well-established procedures enhances the efficiency and safety of these procedures...
  38. ncbi request reprint Influence of vessel diameter on the efficacy of distal protection devices during saphenous vein graft intervention
    Aravind Swaminathan
    University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA
    Am J Cardiol 95:651-4. 2005
    ..In the smallest tertile, MACEs were reduced by 71% with the FilterWire EX compared with the GuardWire (p = 0.05), with the devices showing similar event rates in the other tertiles...
  39. doi request reprint Cerebral embolic exposure during transfemoral and transapical transcatheter aortic valve replacement
    Wilson Y Szeto
    Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104, USA
    J Card Surg 26:348-54. 2011
    ..To characterize the cerebral embolic exposure during transfemoral (TF) and transapical (TA) TAVR...
  40. ncbi request reprint Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non-Q-wave myocardial infarction undergoing percutaneous coronary intervention
    Howard C Herrmann
    University of Pennsylvania Medical Center, Philadelphia 19104, USA
    Am J Cardiol 89:1293-7. 2002
  41. doi request reprint 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation
    Laura Mauri
    Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    J Am Coll Cardiol 62:317-28. 2013
    ..This study sought to evaluate 4-year outcomes of percutaneous repair versus surgery for mitral regurgitation...
  42. ncbi request reprint PCI in African-American women: closing the gender gap
    Ruchira Glaser
    Hospital of the University of Pennsylvania, Philadelphia, PA, USA
    J Invasive Cardiol 19:129-30. 2007
  43. doi request reprint How should I treat prosthetic tricuspid stenosis in an extreme surgical risk patient?
    Scott M Lilly
    Division of Cardiovascular Medicine, Hospital of University of Pennsylvania, Philadelphia, PA 19104, USA
    EuroIntervention 9:407-9. 2013
    ..A 64-year-old female with rheumatic heart disease and multiple prior valve replacements presented with progressive oedema, ascites and dyspnoea on exertion...
  44. ncbi request reprint Alcohol septal ablation complicated by complete heart block and permanent pacemaker failure
    Nicholas Valettas
    Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Catheter Cardiovasc Interv 58:189-93. 2003
    ..We describe a case of alcohol septal ablation complicated by complete heart block and failure to capture by both a permanent pacemaker and an implantable cardioverter defibrillator (ICFD) with pacing capabilities...
  45. ncbi request reprint Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial
    Gregg W Stone
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
    Circulation 105:2347-54. 2002
    ..Also unknown is whether the acuity of the presenting clinical syndrome, which may affect the degree of platelet inhibition required or achieved, influences the response to different antiplatelet agents...
  46. ncbi request reprint Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair
    Elyse Foster
    Department of Cardiology, University of California, San Francisco, California, USA
    Am J Cardiol 100:1577-83. 2007
    ..0; p <0.0018). In conclusion, quantitative assessment of MR is feasible in a multicenter trial, and percutaneous mitral repair with the MitraClip produces a sustained decrease in MR severity to moderate or less for > or =6 months...
  47. doi request reprint Facilitated PCI in patients with ST-elevation myocardial infarction
    Stephen G Ellis
    Department of Cardiovascular Medicine, The Cleveland Clinic, F25, 9500 Euclid Ave, Cleveland, OH 44195, USA
    N Engl J Med 358:2205-17. 2008
    ....
  48. ncbi request reprint Optimizing outcomes in ST-segment elevation myocardial infarction
    Howard C Herrmann
    J Am Coll Cardiol 42:1357-9. 2003
  49. ncbi request reprint Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts
    Gregg W Stone
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, 55 E 59th St, 6th Floor, New York, NY 10022, USA
    Circulation 108:548-53. 2003
    ..Whether filter-based catheters, which offer the inherent advantages of maintained perfusion and ease of use, are as effective for this purpose has not been established...
  50. ncbi request reprint Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofiban
    David J Schneider
    University of Vermont, Burlington, Vermont 05446, USA
    Am J Cardiol 91:334-6. 2003
  51. ncbi request reprint Enhanced early inhibition of platelet aggregation with an increased bolus of tirofiban
    David J Schneider
    University of Vermont, Burlington, Vermont, USA
    Am J Cardiol 90:1421-3. 2002
  52. ncbi request reprint Present and potential future paradigms for the treatment of ST-segment elevation acute myocardial infarction
    Derek P Chew
    Department of Cardiology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44124, USA
    J Invasive Cardiol 14:3A-20A. 2002
  53. ncbi request reprint Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study
    David J Moliterno
    Department of Cardiovascular Medicine and C5 Cleveland Clinic Cardiovascular Coordinating Center, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Lancet 360:355-60. 2002
    ....
  54. ncbi request reprint Comparison of angioplasty with stenting in acute myocardial infarction
    Howard C Herrmann
    N Engl J Med 347:367-8; author reply 367-8. 2002
  55. ncbi request reprint Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up
    Marco Roffi
    Division of Cardiology, University Hospital, Zurich, Switzerland
    Circulation 105:2730-6. 2002
    ..It is unknown whether small-molecule agents confer similar benefits...
  56. ncbi request reprint Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up
    Debabrata Mukherjee
    Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, KY 40536 0200, USA
    Eur Heart J 26:2524-8. 2005
    ..We report here the 1-year mortality of the study population...
  57. ncbi request reprint Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents
    Kathy Makkar
    Mercy Suburban Hospital, Norristown, PA, USA
    Ann Pharmacother 40:1204-7. 2006
    ..To describe 2 cases of rash that occurred following oral administration of both clopidogrel and ticlopidine and to review previously published case reports...
  58. ncbi request reprint Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trial
    Amir Halkin
    Cardiovascular Research Foundation, New York, NY 10022, USA
    Am Heart J 151:915.e1-7. 2006
    ..The late clinical course after treatment with these devices has not been reported...
  59. ncbi request reprint The relationship of obesity to ischemic outcomes following coronary stent placement in contemporary practice
    Jack L Martin
    Main Line Health, Sharpe Strumia Research Foundation of the Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, USA
    Catheter Cardiovasc Interv 67:563-70. 2006
    ..We analyzed the relationship of obesity, determined by body mass index (BMI), to short- and long-term outcomes in the TARGET trial...
  60. ncbi request reprint The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial
    Peter B Berger
    Division of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Am Heart J 149:869-75. 2005
    ..In particular, whether outcome differences exist between agents that are renally excreted (tirofiban) or not (abciximab) in patients with mild renal impairment is not known...
  61. ncbi request reprint Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial
    Ted Feldman
    Evanston Hospital, Cardiology Division Burch 300, Evanston, Illinois 60201, USA
    J Am Coll Cardiol 46:2134-40. 2005
    ..This study sought to evaluate the clinical results of a percutaneous approach to mitral valve repair for mitral regurgitation (MR)...
  62. ncbi request reprint Use of a new 8 French intracardiac echocardiographic catheter to guide device closure of atrial septal defects and patent foramen ovale in small children and adults: initial clinical experience
    Douglas M Luxenberg
    Department of Pediatrics, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA
    J Invasive Cardiol 17:540-5. 2005
    ..We report on the use of a new, 8 Fr ICE catheter that possesses full color Doppler capabilities to guide device closure of ASDs in small children as well as to guide device closure of ASDs and PFOs in adult patients...
  63. ncbi request reprint Percutaneous treatment of valvular heart disease: catheter-based aortic valve replacement and mitral valve repair therapies
    Ted Feldman
    Cardiology Division Burch 300, Evanston Hospital, 2650 Ridge Avenue, Evanston, IL 60201, USA
    Am J Geriatr Cardiol 15:291-301. 2006
    ..The era of percutaneous valve therapy has clearly arrived, and ongoing trials will define the clinical role for these new therapies...
  64. ncbi request reprint The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea: an analysis from the Breathing Not Properly Multinational Study
    Alan H B Wu
    Department of Pathology and Laboratory Medicine, Hartford Hospital, Connecticut, USA
    Diabetes Care 27:2398-404. 2004
    ..We determined the effect of diabetes on B-type natriuretic peptide (BNP) concentrations in patients presenting to the emergency department with dyspnea...
  65. ncbi request reprint B-type natriuretic peptide levels in patients in the emergency department with possible heart failure and previous stable angina pectoris and/or healed myocardial infarction
    James McCord
    Henry Ford Health System, Detroit, Michigan, USA
    Am J Cardiol 96:1370-3. 2005
    ..However, in patients who did not have heart failure, there was a relation between BNP levels and previous stable angina pectoris and/or healed myocardial infarction but no significant independent relation in multiple regression analysis...
  66. ncbi request reprint How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study
    Lori B Daniels
    University of California, San Diego, CA, USA
    Am Heart J 151:999-1005. 2006
    ..We evaluated differential cut-points for BNP in diagnosing acute HF across body mass index levels to determine whether alternative cut-points can improve diagnosis...
  67. ncbi request reprint Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study
    Adam Strunk
    University of California, San Diego, Veterans Affairs San Diego Healthcare System, San Diego, Calif 92161, USA
    Am J Med 119:69.e1-11. 2006
    ..We hypothesized that taking into account the history of congestive heart failure along with other clinical variables would be helpful in this range of B-type natriuretic peptide levels...
  68. ncbi request reprint Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
    Alan S Maisel
    University of California, San Diego, Veterans Affairs Medical Center, San Diego 92161, USA
    N Engl J Med 347:161-7. 2002
    ..B-type natriuretic peptide is released from the cardiac ventricles in response to increased wall tension...
  69. ncbi request reprint ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Arte
    Kim A Eagle
    Circulation 110:1168-76. 2004
  70. ncbi request reprint Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department
    Peter A McCullough
    William Beaumont Hospital, Royal Oak, MI 48073, USA
    Acad Emerg Med 10:198-204. 2003
    ..Heart failure, asthma, and chronic obstructive pulmonary disease (COPD) are syndromes where dyspnea and wheezing are overlapping signs, and hence, these syndromes are often difficult to differentiate...
  71. ncbi request reprint Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study
    Alan S Maisel
    Cardiology 111 A, San Diego VA Medical Center, 3350 La Jolla Village Drive, San Diego, CA 92161, USA
    J Am Coll Cardiol 41:2010-7. 2003
    ..This study examines B-type natriuretic peptide (BNP) levels in patients with systolic versus non-systolic dysfunction presenting with shortness of breath...
  72. ncbi request reprint Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results
    Dean J Kereiakes
    The Lindner Center for Research and Education, 2123 Auburn Ave, Suite 424, Cincinnati, Ohio 45219, USA
    Circulation 108:1310-5. 2003
    ..We assessed the safety and tolerability of phototherapy (PT) with MLu in patients undergoing percutaneous coronary intervention with stent deployment...
  73. ncbi request reprint Transfer for primary angioplasty: the importance of time
    Howard C Herrmann
    Circulation 111:718-20. 2005
  74. ncbi request reprint ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft S
    Kim A Eagle
    Circulation 110:e340-437. 2004
  75. ncbi request reprint ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Arte
    Kim A Eagle
    J Am Coll Cardiol 44:e213-310. 2004
  76. ncbi request reprint Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study
    Alan S Maisel
    University of California, San Diego, Veteran s Affairs Medical Center, San Diego, Calif 92161, USA
    Am Heart J 147:1078-84. 2004
    ..B-type natriuretic peptide (BNP) is secreted from the cardiac ventricles in response to increased wall tension...